• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美罗培南在等渗盐水中复溶后的仿制药稳定性。

Stability of generic brands of meropenem reconstituted in isotonic saline.

作者信息

Carlier M, Stove V, Verstraete A G, De Waele J J

机构信息

Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium -

出版信息

Minerva Anestesiol. 2015 Mar;81(3):283-7. Epub 2014 Sep 15.

PMID:25220554
Abstract

BACKGROUND

Meropenem is a relatively unstable compound when dissolved. Currently, all available data have been derived from tests on the original product from Astrazeneca, and it is unsure if these data can be extrapolated to the stability of other commercially available vials. The aim of this study was therefore to assess the stability of four different brands of meropenem to be used as a prolonged or continuous infusion.

METHODS

Commercially available meropenem vials were reconstituted and mixed with 0.9% sodium chloride to produce solutions with concentrations of 10.20 and 40 mg/mL in polypropylene syringes, which were kept at 25 °C. Samples were taken immediately after preparation and up to 12 hours. Solutions retaining >90% of the initial concentration were considered stable.

RESULTS

The stability was concentration-dependent. At 25 °C, all 10 and 20 mg/mL solutions were stable for 12 hours in 0.9% sodium chloride, while the 40 mg/mL solutions were stable for a maximum of 8 hours. Stability of the different vials of meropenem was comparable for the time period tested (related samples Friedman's two way of analysis of variance by ranks, P=0.282).

CONCLUSION

All tested commercially available vials of meropenem in a concentration of 10 and 20 mg/mL were stable for 12 hours at 25 °C when diluted in 0.9% sodium chloride. The 40 mg/mL solutions were stable for a maximum of 8 hours. This report is the first to show equivalent stability between different commercially available vials of meropenem.

摘要

背景

美罗培南溶解后是一种相对不稳定的化合物。目前,所有可得数据均来自对阿斯利康原研产品的测试,尚不确定这些数据是否能外推至其他市售小瓶的稳定性。因此,本研究的目的是评估四种不同品牌的美罗培南用作延长或持续输注时的稳定性。

方法

将市售美罗培南小瓶复溶,并与0.9%氯化钠混合,在聚丙烯注射器中制成浓度为10、20和40mg/mL的溶液,置于25°C保存。制备后立即取样,直至12小时。保留初始浓度>90%的溶液被认为是稳定的。

结果

稳定性与浓度有关。在25°C时,所有10和20mg/mL的溶液在0.9%氯化钠中12小时均稳定,而40mg/mL的溶液最多稳定8小时。在所测试的时间段内,不同小瓶美罗培南的稳定性相当(相关样本采用弗里德曼双向秩方差分析,P = 0.282)。

结论

所有测试的市售美罗培南小瓶,当在0.9%氯化钠中稀释时,浓度为10和20mg/mL在25°C下12小时均稳定。40mg/mL的溶液最多稳定8小时。本报告首次表明不同市售美罗培南小瓶之间具有等效稳定性。

相似文献

1
Stability of generic brands of meropenem reconstituted in isotonic saline.美罗培南在等渗盐水中复溶后的仿制药稳定性。
Minerva Anestesiol. 2015 Mar;81(3):283-7. Epub 2014 Sep 15.
2
Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device.美罗培南在聚氯乙烯袋和弹性输液装置中的稳定性。
Am J Health Syst Pharm. 2004 Aug 15;61(16):1682-5. doi: 10.1093/ajhp/61.16.1682.
3
Stability of doripenem in vitro in representative infusion solutions and infusion bags.多利培南在代表性输液溶液和输液袋中的体外稳定性。
Clin Ther. 2008 Nov;30(11):2075-87. doi: 10.1016/j.clinthera.2008.11.013.
4
Stability of meropenem in intravenous solutions.美罗培南在静脉输液中的稳定性。
Am J Health Syst Pharm. 1997 Feb 15;54(4):412-21. doi: 10.1093/ajhp/54.4.412.
5
Stability of meropenem in normal saline solution after storage at room temperature.美罗培南在室温储存后于生理盐水中的稳定性。
Southeast Asian J Trop Med Public Health. 2003 Sep;34(3):627-9.
6
Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures.普通美罗培南溶液在正常温度和升高温度下持续输注给药时的稳定性。
Ther Drug Monit. 2014 Oct;36(5):674-6. doi: 10.1097/FTD.0000000000000054.
7
Stability of reconstituted indomethacin sodium trihydrate in original vials and polypropylene syringes.重组吲哚美辛三水合钠在原装瓶和聚丙烯注射器中的稳定性。
Am J Health Syst Pharm. 1998 Jan 15;55(2):154-8. doi: 10.1093/ajhp/55.2.154.
8
Long-term stability of morphine hydrochloride in 0.9% NaCl infusion polyolefin bags after freeze-thaw treatment and in polypropylene syringes at 5 degrees C + 3 degrees C.盐酸吗啡在经冻融处理后的0.9%氯化钠输液聚烯烃袋中以及在5℃±3℃的聚丙烯注射器中的长期稳定性。
Int J Pharm Compd. 2014 Jan-Feb;18(1):78-82.
9
Stability of ceftazidime in plastic syringes and glass vials under various storage conditions.头孢他啶在不同储存条件下于塑料注射器和玻璃瓶中的稳定性。
Am J Hosp Pharm. 1992 Nov;49(11):2765-8.
10
Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures.磷酸替加环素钠-利福平与磷酸替加环素钠-美罗培南在不同温度下静脉输液袋中的稳定性。
Pharmazie. 2020 May 1;75(5):172-176. doi: 10.1691/ph.2020.9155.

引用本文的文献

1
Optimization of meropenem continuous infusion based on Monte Carlo simulation integrating with degradation study.基于蒙特卡洛模拟并结合降解研究的美罗培南持续输注优化
PLoS One. 2024 Dec 23;19(12):e0313764. doi: 10.1371/journal.pone.0313764. eCollection 2024.
2
Optimizing meropenem infusion: the importance of concentration and stability.优化美罗培南输注:浓度和稳定性的重要性。
Intensive Care Med. 2025 Jan;51(1):228-229. doi: 10.1007/s00134-024-07709-9. Epub 2024 Nov 4.
3
Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerations.
在脓毒症重症患者中持续输注β-内酰胺类抗生素:实施要点
Intensive Care Med. 2024 Dec;50(12):2150-2153. doi: 10.1007/s00134-024-07650-x. Epub 2024 Sep 23.
4
Advances in Regenerative and Reconstructive Medicine in the Prevention and Treatment of Bone Infections.再生与重建医学在骨感染防治中的进展
Biology (Basel). 2024 Aug 10;13(8):605. doi: 10.3390/biology13080605.
5
Role of a Real-Time TDM-Based Expert Clinical Pharmacological Advice Program in Optimizing the Early Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Beta-Lactams among Orthotopic Liver Transplant Recipients with Documented or Suspected Gram-Negative Infections.基于实时治疗药物监测的专家临床药理学建议程序在优化原位肝移植受者中持续输注β-内酰胺类药物早期药代动力学/药效学目标达成率方面的作用,这些受者患有确诊或疑似革兰氏阴性感染。
Antibiotics (Basel). 2023 Nov 7;12(11):1599. doi: 10.3390/antibiotics12111599.
6
Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration.基于实时治疗药物监测的专家临床药理学建议程序,用于在接受持续静脉-静脉血液滤过的确诊革兰氏阴性感染重症患者中实现美罗培南持续输注的积极药代动力学/药效学目标。
Antibiotics (Basel). 2023 Oct 10;12(10):1524. doi: 10.3390/antibiotics12101524.
7
Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings.系统评价室温下稳定性关键β-内酰胺类抗生素用于门诊患者延长输注。
Eur J Hosp Pharm. 2023 Dec 27;31(1):2-9. doi: 10.1136/ejhpharm-2023-003855.
8
Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections.持续输注哌拉西林-他唑巴坦或美罗培南在有革兰阴性菌感染记录的泌尿外科患者中的药代动力学/药效学靶点达成情况及微生物学结果
Antibiotics (Basel). 2023 Aug 31;12(9):1388. doi: 10.3390/antibiotics12091388.
9
Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients.美罗培南的软件和治疗药物监测引导给药有望在重症患者中实现高达标率。
Antibiotics (Basel). 2023 Jun 27;12(7):1112. doi: 10.3390/antibiotics12071112.
10
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis.使用群体药代动力学建模和目标达成分析评估 ICU 患者美罗培南的经验性给药方案。
Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0131222. doi: 10.1128/aac.01312-22. Epub 2023 Jan 9.